Practice Makes Perfect: The Rest of the Story in Testicular Cancer as a Model Curable Neoplasm.
暂无分享,去创建一个
W. Lowrance | N. Hanna | T. Powles | P. Albers | S. Srinivas | G. Bosl | D. Feldman | S. Daneshmand | P. Grimison | C. Albany | C. Kollmannsberger | C. Jeldres | K. Fizazi | C. Porter | B. Roth | Mark A Lewis | S. Gillessen | Mark A. Lewis | R. Foster | Craig R. Nichols | T. Tandstad | G. C. Cedermark | Douglas Bank | Maria De Santis | M. De Santis
[1] O. Ståhl,et al. Surveillance vs. adjuvant therapy of clinical stage I testicular tumors – a review and the SWENOTECA experience , 2015, Andrology.
[2] L. Bachrach,et al. Patterns of performance of retroperitoneal lymph node dissections by American urologists: most retroperitoneal lymph node dissections in the United States are performed by low-volume surgeons. , 2014, Urology.
[3] S. Daneshmand,et al. United States trends in patterns of care in clinical stage I testicular cancer: Results from the National Cancer Database (1998-2011). , 2014 .
[4] A. Stewart,et al. Monitoring the delivery of cancer care: Commission on Cancer and National Cancer Data Base. , 2012, Surgical oncology clinics of North America.
[5] L. Collette,et al. Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working Party. , 1999, Journal of the National Cancer Institute.
[6] E. Feuer,et al. Does size matter? Association between number of patients treated and patient outcome in metastatic testicular cancer. , 1999, Journal of the National Cancer Institute.
[7] E. Feuer,et al. After a treatment breakthrough: a comparison of trial and population-based data for advanced testicular cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] S. Kaye,et al. Management of malignant teratoma: does referral to a specialist unit matter? , 1993, The Lancet.
[9] L. Baldetorp,et al. Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] L. Einhorn. Testicular cancer as a model for a curable neoplasm: The Richard and Hinda Rosenthal Foundation Award Lecture. , 1981, Cancer research.